To address the nationwide concern of costly immunotherapy agents, this article features health system inpatient and outpatient strategies that can help mitigate their costs.
Carina Verdier Dolan, PharmD, BCOP
Advertisement
Articles by Carina Verdier Dolan, PharmD, BCOP
Advertisement
Latest Updated Articles
- Evolving Practices in Managing Costly Immunotherapy
February 8th 2016
Advertisement
Advertisement
Trending on AJMC
1
ATTR-CM Incidence, Prevalence Rose Sharply in the US
2
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
3
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
4
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
5